Cargando…
Reading Performance in Blue Cone Monochromacy: Defining an Outcome Measure for a Clinical Trial
PURPOSE: Blue cone monochromacy (BCM), a congenital X-linked retinal disease caused by mutations in the OPN1LW/OPN1MW gene cluster, is under consideration for intravitreal gene therapy. Difficulties with near vision tasks experienced by these patients prompted this study of reading performance as a...
Autores principales: | Semenov, Evelyn P., Sheplock, Rebecca, Roman, Alejandro J., McGuigan, David B., Swider, Malgorzata, Cideciyan, Artur V., Jacobson, Samuel G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726588/ https://www.ncbi.nlm.nih.gov/pubmed/33344057 http://dx.doi.org/10.1167/tvst.9.13.13 |
Ejemplares similares
-
Blue Cone Monochromacy: Visual Function and Efficacy Outcome Measures for Clinical Trials
por: Luo, Xunda, et al.
Publicado: (2015) -
Foveal Therapy in Blue Cone Monochromacy: Predictions of Visual Potential From Artificial Intelligence
por: Sumaroka, Alexander, et al.
Publicado: (2020) -
Color Vision in Blue Cone Monochromacy: Outcome Measures for a Clinical Trial
por: Mascio, Abraham A., et al.
Publicado: (2023) -
Foveal Cone Structure in Patients With Blue Cone Monochromacy
por: Patterson, Emily J., et al.
Publicado: (2022) -
Pupillary Light Reflexes in Severe Photoreceptor Blindness Isolate the Melanopic Component of Intrinsically Photosensitive Retinal Ganglion Cells
por: Charng, Jason, et al.
Publicado: (2017)